Skip to content
  • Home
  • Sectors
    • Financials
    • Healthcare
    • Materials
    • Industrials
    • Energy
    • Information Technology
    • Consumer Staples
    • Utilities
    • Consumer Discretionary
    • Uncategorised
  • News Type
    • Corporate Strategy & Guidance
    • Dividends & Share Buybacks
    • Earnings Reports
    • Industry-Specific News
    • Investor Relations
    • IPO & Public Listings
    • Macroeconomic Impact
    • Mergers & Acquisitions
    • Regulatory News & Compliance
    • Shareholder Updates
    • Stock Price Movements
  • About Us

Latest News

Ausgold Limited (ASX:AUC) Announces $35M Funding for Katanning Gold Project

Orthocell Limited (ASX:OCC) Reports First US Remplir™ Sales Revenue

Mach7 Technologies Limited (ASX:M7T) Updates FY25 Guidance and Share Buyback

Netwealth Group Limited (ASX:NWL) Achieves Record FUA Net Flows in Q2 2025

Zenith Minerals Limited (ASX:ZNC) Completes A$3.5M Rights Issue

Finbar Group Limited (ASX:FRI) Acquires Palmyra Development Site

Mineral Commodities Ltd (ASX:MRC) Announces Update on Skaland Graphite Sale

West African Resources Limited (ASX:WAF) Announces Q2 Production Update

Biome Australia Limited (ASX:BIO) Announces Record Sales Revenue

Resolution Minerals (ASX:RML) Receives Drilling Permits and Advances Acquisition of Horse Heaven Project

The Capital Club

The Capital Club

The Hub of Australian Finance News

  • Home
  • Sectors
    • Financials
    • Healthcare
    • Materials
    • Industrials
    • Energy
    • Information Technology
    • Consumer Staples
    • Utilities
    • Consumer Discretionary
    • Uncategorised
  • News Type
    • Corporate Strategy & Guidance
    • Dividends & Share Buybacks
    • Earnings Reports
    • Industry-Specific News
    • Investor Relations
    • IPO & Public Listings
    • Macroeconomic Impact
    • Mergers & Acquisitions
    • Regulatory News & Compliance
    • Shareholder Updates
    • Stock Price Movements
  • About Us
Saturday, July 12, 2025

Category: Healthcare

Orthocell Limited (ASX:OCC) Reports First US Remplir™ Sales Revenue
ASX-OCC Healthcare

Orthocell Limited (ASX:OCC) Reports First US Remplir™ Sales Revenue

ClubAI 10 July 2025 11:48 am

Orthocell (ASX:OCC) records first US sales revenue from Remplir™ nerve repair product, marking a significant milestone in US expansion.

Industry-Specific NewsInvestor RelationsRegulatory News & Compliance
Mach7 Technologies Limited (ASX:M7T) Updates FY25 Guidance and Share Buyback
ASX-M7T Healthcare Information Technology

Mach7 Technologies Limited (ASX:M7T) Updates FY25 Guidance and Share Buyback

ClubAI 10 July 2025 11:44 am

Mach7 Technologies (ASX:M7T) updates its FY25 guidance, initiates a share buyback, and announces an investor webinar with the new CEO.

Corporate Strategy & GuidanceInvestor Relations
Biome Australia Limited (ASX:BIO) Announces Record Sales Revenue
ASX-BIO Financials Healthcare

Biome Australia Limited (ASX:BIO) Announces Record Sales Revenue

ClubAI 9 July 2025 2:23 pm

Biome Australia Limited (ASX:BIO) reports a 41% revenue increase in FY25, highlighting strong performance in Q4 and June.

Earnings ReportsInvestor Relations
Botanix Pharmaceuticals (ASX:BOT) Reports Strong Sofdra™ Launch Performance
ASX-BOT Healthcare

Botanix Pharmaceuticals (ASX:BOT) Reports Strong Sofdra™ Launch Performance

ClubAI 8 July 2025 12:44 pm

Botanix Pharmaceuticals (ASX:BOT) reports $25M AUD in Sofdra™ sales and expansion of prescriber network, signaling strong market performance.

Industry-Specific NewsInvestor Relations
Nova Eye Medical Limited (ASX:EYE) Achieves Record Revenues for FY25
ASX-EYE Healthcare

Nova Eye Medical Limited (ASX:EYE) Achieves Record Revenues for FY25

ClubAI 8 July 2025 11:14 am

Nova Eye Medical Limited (ASX:EYE) reports record FY25 revenues of A$28.8m, driven by strong US sales and highest Q4 sales on record.

Earnings ReportsIndustry-Specific NewsInvestor Relations
Nanosonics Limited (ASX:NAN) Launches trophon3 and trophon2 Plus
ASX-NAN Healthcare

Nanosonics Limited (ASX:NAN) Launches trophon3 and trophon2 Plus

ClubAI 7 July 2025 11:03 am

Nanosonics Limited (ASX:NAN) launches trophon3 and trophon2 Plus, enhancing infection prevention with faster disinfection and advanced digital integration.

Corporate Strategy & GuidanceIndustry-Specific News
Imugene Limited (ASX:IMU) Receives $5.8m R&D Tax Refund
ASX-IMU Healthcare

Imugene Limited (ASX:IMU) Receives $5.8m R&D Tax Refund

ClubAI 4 July 2025 11:52 am

Imugene Limited (ASX:IMU) receives a A$5.8m R&D tax refund to advance its immuno-oncology pipeline.

Investor RelationsRegulatory News & Compliance
OncoSil Medical Limited (ASX:OSL) Completes PANCOSIL Study Recruitment
ASX-OSL Healthcare

OncoSil Medical Limited (ASX:OSL) Completes PANCOSIL Study Recruitment

ClubAI 4 July 2025 10:32 am

OncoSil Medical (ASX:OSL) completes patient recruitment for the PANCOSIL study, advancing its clinical development of pancreatic cancer treatment.

Corporate Strategy & GuidanceIndustry-Specific News
BCAL Diagnostics Limited (ASX:BDX) Announces Strategic Partnership with Cancer Care Associates
ASX-BDX Healthcare

BCAL Diagnostics Limited (ASX:BDX) Announces Strategic Partnership with Cancer Care Associates

ClubAI 3 July 2025 11:37 am

BCAL Diagnostics Limited (ASX:BDX) partners with Cancer Care Associates to accelerate adoption of BREASTEST plus™ in breast cancer diagnostics.

Corporate Strategy & GuidanceIndustry-Specific News
Pro Medicus Limited (ASX:PME) Signs A$170M, 10-Year Contract with UCHealth
ASX-PME Healthcare Information Technology

Pro Medicus Limited (ASX:PME) Signs A$170M, 10-Year Contract with UCHealth

ClubAI 3 July 2025 11:21 am

Pro Medicus Limited (ASX:PME) signs a A$170M, 10-year contract with UCHealth to implement its Visage 7 imaging platform.

Corporate Strategy & GuidanceIndustry-Specific NewsInvestor Relations

Posts navigation

1 2 … 60 Next

Article Categories

  • Consumer Discretionary
  • Consumer Staples
  • Energy
  • Financials
  • Healthcare
  • Industrials
  • Information Technology
  • Materials
  • Real Estate
  • Telecommunication Services
  • Uncategorised
  • Utilities
  • Publishing Policy
  • About Us
  • Author Biography
The Capital Club